Principal Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Principal Securities's BMY Position: Q2 2026 in Review
Principal Securities increased its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, buying an estimated $491K and bringing the position to 71,067 shares worth $4.09M. The position accounts for 0.05% of the portfolio, ranked #339.
Principal Securities first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Principal Securities held 71,067 shares of Bristol-Myers Squibb worth $4.09M as of Q2 2026.
- Principal Securities bought 8,555 Bristol-Myers Squibb shares in Q2 2026, an estimated $491K.
- Bristol-Myers Squibb made up 0.05% of Principal Securities's portfolio in Q2 2026, its #339 holding.
- Principal Securities first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.